Maravai Lifesciences Holdings, Inc. is a pharmaceutical company based in the United States of America. With a low risk ESG score of 16.1, Maravai LifeSciences focuses on enabling drug therapies, diagnostics, and vaccines while supporting research on human diseases. The company's main segments are Nucleic acid production and biologics safety testing, with a primary focus on manufacturing and selling nucleic acid products. Their products support research, therapeutic, and vaccine programs, as well as provide research products for protein labeling and detection.